CardioExchange Archive

February 23rd, 2015

Selections from Richard Lehman’s Literature Review: February 23rd

Richard Lehman, BM, BCh, MRCGP

This week’s topics include a comparison of fondaparinux and low-molecular-weight heparin in patients with non-STEMI and a study of multiple BP medications, achieved BP, and mortality in older nursing home residents.

---

November 3rd, 2014

Selections from Richard Lehman’s Literature Review: November 3rd

Richard Lehman, BM, BCh, MRCGP

This week’s topics include dual-antiplatelet treatment beyond one year after DES implantation, reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome, and more.

---

September 1st, 2013

Inside the ACCOAST Trial of Pretreatment Prasugrel

Gilles Montalescot, MD, PhD, John Ryan, MD, Richard A. Lange, MD, MBA and L. David Hillis, MD

Gilles Montalescot, lead investigator of the ACCOAST trial, discusses why prasugrel pretreatment did not benefit patients with non–ST-segment elevation acute coronary syndromes.

---

November 8th, 2010

Non-STEMI Patients Delay Seeking Help Just As Long as STEMI Patients

Larry Husten, PHD

Non-STEMI patients delayed going to the hospital for as long in 2006 as they did in 2001, according to a report published in the Archives of Internal Medicine. Henry Ting and colleagues analyzed data from 104,622 non-STEMI patients enrolled in the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of […]

---

August 9th, 2010

Prior Medication Use Shifts Balance of MIs

Larry Husten, PHD

Patients who present with MI and are taking aspirin, beta-blockers, ACE inhibitors, or statins are more likely to have a non-STEMI than a STEMI, according to findings from a large Swedish registry published in the Archives of Internal Medicine. Lena Björck and colleagues analyzed data from over 100,000 consecutive admissions for MI. Some 61% of STEMI […]

---